Fty720 (Fingolimod)
Posted Date: May 15, 2019
- Investigator: Aram Zabeti
- Type of Study: Observational/Survey
The main purpose of this study is to evaluate long-term safety of fingolimod and to further explore the frequency of selected safety outcomes in patients with MS, either newly prescribed fingolimod or receiving another approved MS medication. This study is being conducted to collect additional safe
Criteria:
You Are Being Asked To Take Part In This Research Study Because You Are At Least 18 Years Of Age And
Keywords:
Fingolimod, Multiple Sclerosis, Relapsing Remitting
For More Information:
Katie Krier
513-558-0169
krierci@ucmail.uc.edu